Table 4.
Treatment outcomes in different treatment groups after imputation: Secondary outcomes.
| Available data | Intent to treat data | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Tbaseline | Tpost-treatment | Tpost-treatment | ||||||||||||
| Measure | Group | N | M(SD) | N | M(SD) | da | p | N | M(SD) | da | p | ANOVAb | Factor | p |
| MSI-BPD | DBT-PTSD | 42 | 6.47 (2.19) | 21 | 5.24 (3.05) | 0.65 | .007 | 42 | 5.63 (2.78) | 0.42 | .009 | F(1,129) = 17.18 | Time | <.001 |
| TAU | 89 | 5.54 (2.30) | 53 | 4.27 (2.57) | 0.48 | <.001 | 89 | 4.83 (2,53) | 0.36 | .001 | F(1,129) = 4.311 | Group | .032 | |
| dc | 0.36 | .170 | 0.31 | .102 | F(1,129) = 0.121 | Gr. x ti. | .728 | |||||||
| PHQ-9 | DBT-PTSD | 43 | 17.7 (4.41) | 22 | 11.5(4.96) | 1.18 | <.001 | 43 | 14.3 (5.51) | 0.65 | <.001 | F(1,149) = 68.60 | Time | <.001 |
| TAU | 108 | 16.9 (4.86) | 66 | 12.5 (4.81) | 1.28 | <.001 | 108 | 13.8 (5.04) | 0.78 | <.001 | F(1,149) = 0.559 | Group | .456 | |
| dc | 0.19 | .441 | 0.09 | .637 | F(1,149) = 0.169 | Gr. x ti. | .681 | |||||||
| GAD-7 | DBT-PTSD | 44 | 13. (3.81) | 22 | 9.27 (5.28) | 1.04 | <.001 | 44 | 11.2 (5.01) | 0.59 | <.001 | F(1,150) = 46.96 | Time | <.001 |
| TAU | 108 | 14.2 (4.24) | 66 | 10.6 (4.73) | 0.89 | <.001 | 108 | 11.8 (4.85) | 0.61 | <.001 | F(1,150) = 0.432 | Group | .512 | |
| dc | 0.26 | .291 | 0.11 | .524 | F(1,150) = 0.053 | Gr. x ti. | .818 | |||||||
| ERQ Reappraisal | DBT-PTSD | 42 | 22.5 (7.81) | 21 | 28.8 (5.98) | 1.01 | <.001 | 42 | 26.2 (7.74) | 0.58 | <.001 | F(1,133) = 26.19 | Time | <.001 |
| TAU | 93 | 22.5 (7.77) | 55 | 26.1 (6.46) | 0.48 | <.001 | 93 | 24.7 (6.95) | 0.36 | <.001 | F(1,133) = 0.35 | Group | .556 | |
| dc | 0.44 | .094 | 0.21 | .260 | F(1,133) = 1.79 | Gr. x ti. | .183 | |||||||
| ERQ Suppression | DBT-PTSD | 42 | 19.1 (5.09) | 21 | 16.5 (4.93) | 0.70 | .004 | 42 | 17.3 (4.73) | 0.45 | .006 | F(1,134) = 5.26 | Time | .023 |
| TAU | 94 | 17.0 (5.53) | 56 | 17.2 (4.48) | 0.01 | .921 | 94 | 17.0 (4.81) | 0.01 | .921 | F(1.134) = 1.91 | Group | .169 | |
| dc | 0.14 | .590 | 0.06 | .748 | F(1.134) = 5.78 | Gr. x ti. | .018 | |||||||
| WHODAS | DBT-PTSD | 44 | 22.8 (8.05) | 22 | 18.4 (8.57) | 0.99 | <.001 | 44 | 19.8 (7.95) | 0.58 | <.001 | F(1,140) = 38.6 | Time | <.001 |
| TAU | 98 | 22.9 (8.07) | 62 | 18.6 (8.26) | 0.76 | <.001 | 98 | 20.0 (7.97) | 0.55 | <.001 | F(1,140) = 0.01 | Group | .928 | |
| dc | 0.03 | .907 | 0.02 | .901 | F(1,140) = 0.01 | Gr. x ti. | .909 | |||||||
Note: DBT-PTSD = Dialectical Behavioural Therapy – Posttraumatic Stress Disorder, TAU = Treatment as usual, MSI-BPD = McLean Screening Instrument for Borderline Personality Disorder, PHQ-9 = Patient Health Questionnaire-9, GAD-7 = Brief Measure for assessing General Anxiety Disorder, ERQ = Emotion Regulation Questionnaire, WHODAS = WHO Disability Assessment Schedule.
Cohen’s d was computed using the pooled standard deviation of scores at admission (t1) and discharge (t2).
Repeated measures analysis of variance with intent to treat data.
Cohen’s d was computed using the pooled standard deviation of scores at discharge (t2) from the DBT-PTSD and TAU groups.